• 1
    Erwig LP, Henson PM.Clearance of apoptotic cells by phagocytes.Cell Death Differ2008;15:24350.
  • 2
    Gaipl US, Munoz LE, Grossmayer G, Lauber K, Franz S, Sarter K, et al.Clearance deficiency and systemic lupus erythematosus (SLE).J Autoimmun2007;28:11421.
  • 3
    Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR.Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus.Arthritis Rheum1998;41:124150.
  • 4
    Baumann I, Kolowos W, Voll RE, Manger B, Gaipl U, Neuhuber WL, et al.Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus.Arthritis Rheum2002;46:191201.
  • 5
    Mitchell DA, Pickering MC, Warren J, Fossati-Jimack L, Cortes-Hernandez J, Cook HT, et al.C1q deficiency and autoimmunity: the effects of genetic background on disease expression.J Immunol2002;168:253843.
  • 6
    Lu Q, Lemke G.Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family.Science2001;293:30611.
  • 7
    Bondanza A, Zimmermann VS, Dell'Antonio G, Cin ED, Balestrieri G, Tincani A, et al.Requirement of dying cells and environmental adjuvants for the induction of autoimmunity.Arthritis Rheum2004;50:154960.
  • 8
    Kalaaji M, Fenton KA, Mortensen ES, Olsen R, Sturfelt G, Alm P, et al.Glomerular apoptotic nucleosomes are central target structures for nephritogenic antibodies in human SLE nephritis.Kidney Int2007;71:66472.
  • 9
    Sarmiento LF, Munoz LE, Chirinos P, Bianco NE, Zabaleta-Lanz ME.Opsonization by anti-dsDNA antibodies of apoptotic cells in systemic lupus erythematosus.Autoimmunity2007;40:3379.
  • 10
    Grossmayer GE, Munoz LE, Weber CK, Franz S, Voll RE, Kern PM, et al.IgG autoantibodies bound to surfaces of necrotic cells and complement C4 comprise the phagocytosis promoting activity for necrotic cells of systemic lupus erythaematosus sera.Ann Rheum Dis2008;67:162632.
  • 11
    Bave U, Vallin H, Alm GV, Ronnblom L.Activation of natural interferon-α producing cells by apoptotic U937 cells combined with lupus IgG and its regulation by cytokines.J Autoimmun2001;17:7180.
  • 12
    Munoz LE, Janko C, Grossmayer GE, Frey B, Voll RE, Kern P, et al.Remnants of secondarily necrotic cells fuel inflammation in systemic lupus erythematosus.Arthritis Rheum2009;60:173342.
  • 13
    Santer DM, Wiedeman AE, Teal TH, Ghosh P, Elkon KB.Plasmacytoid dendritic cells and C1q differentially regulate inflammatory gene induction by lupus immune complexes.J Immunol2012;188:90215.
  • 14
    Reefman E, Horst G, Nijk MT, Limburg PC, Kallenberg CG, Bijl M.Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcγ receptor–dependent mechanism.Arthritis Rheum2007;56:3399411.
  • 15
    Gronwall C, Akhter E, Oh C, Burlingame RW, Petri M, Silverman GJ.IgM autoantibodies to distinct apoptosis-associated antigens correlate with protection from cardiovascular events and renal disease in patients with SLE.Clin Immunol2012;142:3908.
  • 16
    Cappione AJ, Pugh-Bernard AE, Anolik JH, Sanz I.Lupus IgG VH4.34 antibodies bind to a 220-kDa glycoform of CD45/B220 on the surface of human B lymphocytes.J Immunol2004;172:4298307.
  • 17
    Cappione A III, Anolik JH, Pugh-Bernard A, Barnard J, Dutcher P, Silverman G, et al.Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus.J Clin Invest2005;115:320516.
  • 18
    Isenberg D, Spellerberg M, Williams W, Griffiths M, Stevenson F.Identification of the 9G4 idiotope in systemic lupus erythematosus.Br J Rheumatol1993;32:87682.
  • 19
    Isenberg DA, McClure C, Farewell V, Spellerberg M, Williams W, Cambridge G, et al.Correlation of 9G4 idiotope with disease activity in patients with systemic lupus erythematosus.Ann Rheum Dis1998;57:56670.
  • 20
    Van Vollenhoven RF, Bieber MM, Powell MJ, Gupta PK, Bhat NM, Richards KL, et al.VH4-34 encoded antibodies in systemic lupus erythematosus: a specific diagnostic marker that correlates with clinical disease characteristics.J Rheumatol1999;26:172733.
  • 21
    Bhat NM, Lee LM, van Vollenhoven RF, Teng NN, Bieber MM.VH4-34 encoded antibody in systemic lupus erythematosus: effect of isotype.J Rheumatol2002;29:211421.
  • 22
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al.The 1982 revised criteria for the classification of systemic lupus erythematosus.Arthritis Rheum1982;25:12717.
  • 23
    Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang DH, and the Committee on Prognosis Studies in SLE.Derivation of the SLEDAI: a disease activity index for lupus patients.Arthritis Rheum1992;35:63040.
  • 24
    Henery S, George T, Hall B, Basiji D, Ortyn W, Morrissey P.Quantitative image based apoptotic index measurement using multispectral imaging flow cytometry: a comparison with standard photometric methods.Apoptosis2008;13:105463.
  • 25
    Tiller T, Meffre E, Yurasov S, Tsuiji M, Nussenzweig MC, Wardemann H.Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning [published erratum appears in J Immunol Methods 2008;334:142].J Immunol Methods2008;329:11224.
  • 26
    Richardson C, Chida AS, Adowitz D, Silver L, Fox E, Jenks SA, et al.Molecular determinants of 9G4 B cells autoreactivity and selection in human SLE.J Immunol. In press.
  • 27
    Milner EC, Anolik J, Cappione A, Sanz I.Human innate B cells: a link between host defense and autoimmunity?Springer Semin Immunopathol2005;26:43352.
  • 28
    Pugh-Bernard A, Hocknell K, Cappione A, Anolik J, Sanz I.VH4-34 anti-I/i autoantibodies recognize apoptotic cells [abstract].Arthritis Rheum2002;46 Suppl:S126.
  • 29
    Catera R, Silverman GJ, Hatzi K, Seiler T, Didier S, Zhang L, et al.Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation.Mol Med2008;14:66574.
  • 30
    Silberstein LE, George A, Durdik JM, Kipps TJ.The V4-34 encoded anti-i autoantibodies recognize a large subset of human and mouse B-cells.Blood Cells Mol Dis1996;22:12638.
  • 31
    Satoh M, Chan EK, Ho LA, Rose KM, Parks CG, Cohn RD, et al.Prevalence and sociodemographic correlates of antinuclear antibodies in the United States.Arthritis Rheum2012;64:231927.
  • 32
    Saisoong S, Eiam-Ong S, Hanvivatvong O.Correlations between antinucleosome antibodies and anti-double-stranded DNA antibodies, C3, C4, and clinical activity in lupus patients.Clin Exp Rheumatol2006;24:518.
  • 33
    Chang MK, Binder CJ, Miller YI, Subbanagounder G, Silverman GJ, Berliner JA, et al.Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory.J Exp Med2004;200:135970.
  • 34
    Radic MZ, Shah K, Zhang W, Lu Q, Lemke G, Hilliard GM.Heterogeneous nuclear ribonucleoprotein P2 is an autoantibody target in mice deficient for Mer, Axl, and Tyro3 receptor tyrosine kinases.J Immunol2006;176:6874.
  • 35
    Cline AM, Radic MZ.Apoptosis, subcellular particles, and autoimmunity.Clin Immunol2004;112:17582.
  • 36
    Casciola-Rosen LA, Anhalt G, Rosen A.Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes.J Exp Med1994;179:131730.
  • 37
    Neeli I, Richardson MM, Khan SN, Nicolo D, Monestier M, Radic MZ.Divergent members of a single autoreactive B cell clone retain specificity for apoptotic blebs.Mol Immunol2007;44:191421.
  • 38
    Das J, Arora P, Gracias D, Praveen A, Raj BP, Martin E, et al.Endogenous humoral autoreactive immune responses to apoptotic cells: effects on phagocytic uptake, chemotactic migration and antigenic spread.Eur J Immunol2008;38:356174.
  • 39
    Urbonaviciute V, Furnrohr BG, Meister S, Munoz L, Heyder P, De Marchis F, et al.Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE.J Exp Med2008;205:300718.
  • 40
    Ando K, Hagiwara T, Beppu M, Kikugawa K.Naturally occurring anti-band 3 antibody binds to apoptotic human T-lymphoid cell line Jurkat through sialylated poly-N-acetyllactosaminyl saccharide chains on the cell surface.Biochem Biophys Res Commun2000;275:4127.
  • 41
    Eda S, Yamanaka M, Beppu M.Carbohydrate-mediated phagocytic recognition of early apoptotic cells undergoing transient capping of CD43 glycoprotein.J Biol Chem2004;279:596774.
  • 42
    Huynh ML, Fadok VA, Henson PM.Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-β1 secretion and the resolution of inflammation.J Clin Invest2002;109:4150.
  • 43
    Sule S, Rosen A, Petri M, Akhter E, Andrade F.Abnormal production of pro- and anti-inflammatory cytokines by lupus monocytes in response to apoptotic cells.PLoS One2011;6:e17495.
  • 44
    Frisoni L, McPhie L, Colonna L, Sriram U, Monestier M, Gallucci S, et al.Nuclear autoantigen translocation and autoantibody opsonization lead to increased dendritic cell phagocytosis and presentation of nuclear antigens: a novel pathogenic pathway for autoimmunity?J Immunol2005;175:2692701.
  • 45
    Bhat NM, Bieber MM, Spellerberg MB, Stevenson FK, Teng NN.Recognition of auto- and exoantigens by V4-34 gene encoded antibodies.Scand J Immunol2000;51:13440.
  • 46
    Datta SK.Major peptide autoepitopes for nucleosome-centered T and B cell interaction in human and murine lupus.Ann N Y Acad Sci2003;987:7990.
  • 47
    Rosen A, Casciola-Rosen L.Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease.Cell Death Differ1999;6:612.
  • 48
    Biggiogera M, Bottone MG, Scovassi AI, Soldani C, Vecchio L, Pellicciari C.Rearrangement of nuclear ribonucleoprotein (RNP)-containing structures during apoptosis and transcriptional arrest.Biol Cell2004;96:60315.
  • 49
    Li Y, Spellerberg MB, Stevenson FK, Capra JD, Potter KN.The I binding specificity of human VH 4-34 (VH 4-21) encoded antibodies is determined by both VH framework region 1 and complementarity determining region 3.J Mol Biol1996;256:57789.
  • 50
    Kobie JJ, Alcena DC, Zheng B, Bryk P, Mattiacio JL, Brewer M, et al.9G4 autoreactivity is increased in HIV-infected patients and correlates with HIV broadly neutralizing serum activity.PLoS One2012;7:e35356.